-
-
Call more information
660-596-2224 -
Authors: Jane Ahn, MD et al ASA Monitor June 2023, Vol. 87, 24. Volatile hydrofluorocarbon anesthetics (sevoflurane, isoflurane, and desflurane) and nitrous oxide are ubiquitous in perioperative anesthetic practice and are estimated to contribute between 0.01% to 0.1% of total global greenhouse gas (GHG) emissions (BMJ 2022 8;377:o1301; asamonitor.pub/40kSYby). When used in clinical practice, volatile anesthetics undergo […]
Read MoreAuthors: Demyan A, Cosio D. Pract Pain Manag. 2023 MayJune;23(3). A person’s attachment style, whether secure or insecure, not only impacts how they experience pain but also their expectations of treatment and clinicians. Identifying these styles early on can improve pain management outcomes. Attachment theory aims to explain differences in individuals’ perceptions of belonging, security, […]
Read MoreAuthors: George Tewfik, MD, MBA, FASA et al ASA Monitor June 2023, Vol. 87, 25–26. Humans have a tendency to take things for granted until they experience a shortage or interruption in supply. Who thinks about the electrical grid until their lights won’t turn on? Or about the water flowing from the faucet until it comes […]
Read MoreAuthors: Korina Katsaliaki, PhD et al ASA Monitor June 2023, Vol. 87, 21–23. During the last few years, there have been reports of shortages of anesthesiology supplies and drugs. These shortages have been caused by a combination of factors, including increased demand, manufacturing issues, and disruptions in the supply chain. For example, the use of propofol, […]
Read MoreAuthors: Ming-Chun Hsieh, Ph.D. et al Anesthesiology June 2023, Vol. 138, 634–655. Background Nonsense-mediated messenger RNA (mRNA) decay increases targeted mRNA degradation and has been implicated in the regulation of gene expression in neurons. The authors hypothesized that nonsense-mediated μ-opioid receptor mRNA decay in the spinal cord is involved in the development of neuropathic allodynia–like behavior […]
Read MoreAuthors: Umar Kamal, MD et al ASA Monitor June 2023, Vol. 87, 22–23. Albuterol, bupivacaine, hydrocortisone, and dopamine – these are only four of the approximately 260 drugs that have experienced national shortages over the past 12 months (asamonitor.pub/41eZ3Hx; asamonitor.pub/40TNKVa). These scarcities have led to treatment delays, rationing, and, in some cases, changes to therapeutic plans (asamonitor.pub/3mxTgh5). […]
Read MoreAuthor: Lalitha Sundararaman, MBBS, MD ASA Monitor June 2023, Vol. 87, 18–19. Health care expenditure (HCE) in the United States stands at around $4.3 trillion annually – about 18% of its gross domestic product (GDP) (JAMA 2019;322:1501-9). A study in JAMA revealed a startling fact about this remarkable number – that nearly 20%-30% of it is wasteful (JAMA […]
Read MoreAuthors: Bettinger J, Yaras R. Pract Pain Manage. 2023 MayJune:23(2). How to apply the updated CDC Clinical Practice Guideline for Prescribing Opioids for Pain in individuals starting opioid therapy. In this series of analyses, we have broken down the various aspects of the newly released revisions to the CDC Clinical Practice Guideline for Prescribing Opioids for Pain […]
Read MoreAuthor: Daniel Vukelich, JD ASA Monitor June 2023, Vol. 87, 20. The February 2023 report issued by the U.N. Intergovernmental Panel on Climate Change stated that if human-caused global warming isn’t slowed to a couple tenths of a degree, deadly heat, drought, fires, and floods could impact the planet in “potentially irreversible” ways. Putting off cuts […]
Read MoreAuthor: Heidi Splete Practical Pain Management May/June 2023 A new study explores the role of sex hormones and CGRP as a contributor to the higher prevalence of migraine in women compared to men. Migraine headaches are approximately three times more common in women than in men, but the prevalence of migraine in women decreases after […]
Read More